UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Volltextzugriff (PDF)

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1147-1155

2015

Volltextzugriff (PDF)

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

The journal of clinical endocrinology and metabolism, 2014-05, Vol.99 (5), p.1694-1700

2014

Volltextzugriff (PDF)

First-in-human testing of a wirelessly controlled drug delivery microchip

Science translational medicine, 2012-02, Vol.4 (122), p.122ra21

2012

Volltextzugriff (PDF)

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

The Lancet (British edition), 2013-07, Vol.382 (9886), p.50-56

2013

Volltextzugriff (PDF)

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

Journal of bone and mineral research, 2011-03, Vol.26 (3), p.503-511

2011

Volltextzugriff (PDF)

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐HRpQCT Study

Journal of bone and mineral research, 2015-01, Vol.30 (1), p.39-45

2015

Volltextzugriff (PDF)

Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis

Bone (New York, N.Y.), 2023-02, Vol.167, p.116618-116618, Article 116618

2023

Volltextzugriff (PDF)

Combination and sequential treatment in women with postmenopausal osteoporosis

Expert opinion on pharmacotherapy, 2020-03, Vol.21 (4), p.477-490

2020

Volltextzugriff (PDF)

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2010-04, Vol.95 (4), p.1838-1845

2010

Volltextzugriff (PDF)

Cortical Bone: A Challenging Geography

Journal of bone and mineral research, 2015-01, Vol.30 (1), p.24-29

2015

Volltextzugriff (PDF)

Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment

European review for medical and pharmacological sciences, 2021-05, Vol.25 (9), p.3557

2021

Volltextzugriff (PDF)

Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study

Journal of bone and mineral research, 2024-07, Vol.39 (6), p.672-682

2024

Volltextzugriff (PDF)

Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study

Spine (Philadelphia, Pa. 1976), 2012-11, Vol.37 (23), p.E1464-E1468

2012

Volltextzugriff (PDF)

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis

Frontiers in endocrinology (Lausanne), 2024-09, Vol.15, p.1431676

2024

Volltextzugriff (PDF)

Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass

Journal of bone and mineral research, 2017-09, Vol.32 (9), p.1956-1962

2017

Volltextzugriff (PDF)

Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study

Journal of bone and joint surgery. American volume, 2017-03, Vol.99 (5), p.365-372

2017

Volltextzugriff (PDF)

Administration of teriparatide for four years cyclically compared to two years daily in treatment Naïve and alendronate treated women

Bone (New York, N.Y.), 2019-03, Vol.120, p.246-253

2019

Volltextzugriff (PDF)

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3097-3106

2012

Volltextzugriff (PDF)

Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis

Pharmaceutical research, 2011-01, Vol.28 (1), p.159-165

2011

Volltextzugriff (PDF)

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial

The journal of clinical endocrinology and metabolism, 2020-11, Vol.105 (11), p.1-3395

2020

Volltextzugriff (PDF)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium

Osteoporosis international, 2024-07, Vol.35 (7), p.1173-1183

2024

Volltextzugriff (PDF)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study

Osteoporosis international, 2019-11, Vol.30 (11), p.2321-2331

2019

Volltextzugriff (PDF)

Effects of daily versus weekly teriparatide for medication‐related osteonecrosis of the jaw: A case–control study

Oral diseases, 2024-07, Vol.30 (5), p.3286-3295

2024

Volltextzugriff (PDF)

Bisphosphonate and Teriparatide Use in Thoracolumbar Spinal Fusion: A Systematic Review and Meta-analysis of Comparative Studies

Spine (Philadelphia, Pa. 1976), 2018-09, Vol.43 (17), p.E1014-E1023

2018

Volltextzugriff (PDF)

1 – 25 von 550

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(488)
Mit Volltextzugriff
(403)

Publikationsform

Artikel
(549)
magazinearticle
(1)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(456)
Science & Technology
(452)
Life Sciences & Biomedicine
(447)
Teriparatide - Administration & Dosage
(402)
Female
(380)
Bone Density Conservation Agents - Administration & Dosage
(276)
Teriparatide
(239)
Endocrinology & Metabolism
(223)
Osteoporosis
(213)
Aged
(208)
Male
(205)
Bone Density - Drug Effects
(203)
Teriparatide - Therapeutic Use
(198)
Middle Aged
(186)
Osteoporosis - Drug Therapy
(182)
Animals
(172)
Bone Density Conservation Agents - Therapeutic Use
(160)
Biological And Medical Sciences
(137)
Orthopedics
(130)
Osteoporosis, Postmenopausal - Drug Therapy
(130)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

First-in-human testing of a wirelessly controlled drug delivery microchip

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐HRpQCT Study

Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis

Combination and sequential treatment in women with postmenopausal osteoporosis

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

Cortical Bone: A Challenging Geography

Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment

Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study

Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis

Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass

Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study

Administration of teriparatide for four years cyclically compared to two years daily in treatment Naïve and alendronate treated women

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study

Effects of daily versus weekly teriparatide for medication‐related osteonecrosis of the jaw: A case–control study

Bisphosphonate and Teriparatide Use in Thoracolumbar Spinal Fusion: A Systematic Review and Meta-analysis of Comparative Studies

Suchergebnisse filtern